Main > RHEUMATOLOGY > IN. S. PsA>Treat>JAK Inh. Tab.

---

IN. S. PsA>Treat>JAK Inh. Tab.'s subsections
(*) IN Approval Date: 2022. 02.17
Company
Generic Name: Tofacitinib
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2022. 06.28
PR Release Web-Site

IN. S. PsA>Treat>JAK Inh. Tab.'s products
This section has no products